eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | chronic myelocytic leukemia |
| Symptom | C0032227|pleural effusion |
| Sentences | 5 |
| PubMedID- 20463821 | The burden of managing pleural effusions in patients with chronic myelogenous leukemia post-imatinib failure: a literature-based economic analysis. |
| PubMedID- 22787303 | pleural effusion in patients with chronic myeloid leukemia (cml) is very rare and poorly understood. |
| PubMedID- 19924787 | Dasatinib 100 mg once daily minimizes the occurrence of pleural effusion in patients with chronic myeloid leukemia in chronic phase and efficacy is unaffected in patients who develop pleural effusion. |
| PubMedID- 22587385 | The economic burden of pleural effusions in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors. |
| PubMedID- 20191333 | Safe switching from dasatinib to nilotinib after a 1-month off-drug period for persistent pleural effusion in patients with chronic myelogenous leukemia in chronic phase. |
Page: 1